Analyst Ratings for Zynerba Pharmaceuticals (ZYNE) [Sells]
ZYNE Rating Summary
ZYNE Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$1.11 (-14.6%)
* Over Last 12-Mos
Rating Score: 3.6 / 10 Percentile Rank: 34%
Rating Score: 3.6 / 10 Percentile Rank: 34%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|